CALO', LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.026
AS - Asia 4.511
EU - Europa 4.422
SA - Sud America 120
AF - Africa 21
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 36.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.958
SG - Singapore 2.303
CN - Cina 1.555
IT - Italia 1.107
DE - Germania 666
FI - Finlandia 639
SE - Svezia 483
UA - Ucraina 346
GB - Regno Unito 334
FR - Francia 322
VN - Vietnam 257
HK - Hong Kong 223
RU - Federazione Russa 220
NL - Olanda 105
BR - Brasile 103
IN - India 77
IE - Irlanda 61
CA - Canada 60
JP - Giappone 28
SI - Slovenia 22
AT - Austria 20
PL - Polonia 18
CH - Svizzera 17
ES - Italia 16
CI - Costa d'Avorio 14
TR - Turchia 11
AU - Australia 9
BE - Belgio 9
GE - Georgia 9
NZ - Nuova Zelanda 8
EC - Ecuador 7
EU - Europa 7
ID - Indonesia 7
LT - Lituania 7
MX - Messico 6
PH - Filippine 6
CO - Colombia 5
AL - Albania 4
BG - Bulgaria 4
MK - Macedonia 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
GR - Grecia 3
IQ - Iraq 3
JO - Giordania 3
PK - Pakistan 3
SA - Arabia Saudita 3
CR - Costa Rica 2
DZ - Algeria 2
IR - Iran 2
KR - Corea 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
VE - Venezuela 2
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 36.124
Salva come PNG Salva come JPEG
Città #
Fairfield 4.233
Woodbridge 2.360
Houston 2.172
Chandler 2.089
Ashburn 1.831
Wilmington 1.532
Seattle 1.494
Jacksonville 1.470
Cambridge 1.411
Ann Arbor 1.394
Singapore 990
Boardman 832
Princeton 738
Santa Clara 503
Medford 444
San Diego 421
Beijing 336
Roxbury 331
Des Moines 322
Nanjing 317
Helsinki 314
Padova 290
Dong Ket 257
Hong Kong 222
Shenyang 95
New York 88
Guangzhou 87
Nanchang 86
Milan 85
Hebei 84
London 62
Munich 61
Jiaxing 55
Ogden 54
Dublin 53
Norwalk 53
Tianjin 53
Redwood City 43
Changsha 40
Jinan 36
Mcallen 35
Rome 32
Kharkiv 31
Falkenstein 29
Montréal 28
Nuremberg 28
Shanghai 28
Amsterdam 27
Falls Church 27
Kilburn 26
Vicenza 25
Washington 25
Borås 23
Los Angeles 20
Pune 20
Curitiba 19
Zhengzhou 16
Turin 15
Verona 15
Abidjan 14
Dallas 13
Lappeenranta 12
Nürnberg 12
Bologna 11
Frankfurt am Main 11
Lausanne 11
Toronto 11
Atlanta 10
Hefei 10
Kunming 10
Vienna 10
Mestre 9
Palermo 9
Prescot 9
Tbilisi 9
Tokyo 9
Acton 8
Brussels 8
Chicago 8
Dronten 8
Hangzhou 8
Joetsu 8
Malo 8
Ottawa 8
Portici 8
São Paulo 8
Tappahannock 8
Venice 8
Chiswick 7
Hounslow 7
Lanzhou 7
Ningbo 7
Silea 7
Simi Valley 7
Southwark 7
Detroit 6
Indiana 6
Naples 6
New Bedfont 6
Phoenix 6
Totale 28.162
Salva come PNG Salva come JPEG
Nome #
Potential role of phytochemicals in metabolic syndrome prevention and therapy 264
Ruolo dei fattori vasoattivi di origine endoteliale nella patogenesi dell'ipertensione arteriosa.Valutazione fisiopatologiche e terapeutiche 163
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 159
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 159
Endothelin-1 Drives Epithelial-Mesenchymal Transition In Hypertensive Nephroangiosclerosis 148
Searching for an additional treatment to slowing the progression of Fabry disease 148
Kidney Involvement in Asia Syndrome: Case Report of an Uncommon Nephrotic Syndrome 147
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 141
Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder 133
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 132
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 131
A UNIQUE CASE OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS FOLLOWING DEXAMETHASONE/BORTEZOMIB/THALIDOMIDE TREATMENT FOR MYELOMA 131
THE MEDICAL AND ENDOVASCULAR TREATMENT OF ATHEROSCLEROTIC RENAL ARTERY STENOSIS (METRAS) STUDY: RATIONALE AND STUDY DESIGN 130
Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways 128
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 127
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 127
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 126
A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis? 124
The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. 123
Evaluating nephrocheck as a predictive tool for acute kidney injury 123
Aldosterone, inflammation, and preeclampsia. 122
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. 121
The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design. 121
Oral burning with dysphagia and weight loss 120
Thymoma-associated renal pathology: Is renal biopsy always necessary? A clinical problem-solving exercise and teaching example for physicians. 120
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 120
Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms 119
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 116
HO-1 Attenuates Hypertension-Induced Inflammation/Oxidative Stress: Support From Bartter's/Gitelman's Patients 115
Salivary Phosphorus and Phosphate Content of Beverages: Implications for the Treatment of Uremic Hyperphosphatemia 114
Salivary Phosphate-Binding Chewing Gum Reduces Hyperphosphatemia in Dialysis Patients 114
EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1 112
Comment on: Hemodiafiltration in a critical dialysis patient with H1N1 influenza A 112
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 112
Identification of the mineralocorticoid receptor in human spermatozoa 112
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 112
Myocardial perfusion defects in Bartter and Gitelman syndromes 111
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 111
Hypertension and Its Treatment in the Elderly 111
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. 109
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 109
IDIOPATHIC HYPERCALCIURIA: O2-NO RELATIONSHIP AND ALTERED BONE METABOLISM 109
Hemodiafiltration and oxidative stress in dialysis patients. 108
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 108
PHOS-FAKE or PHOS-FATAL - does intake of phosphate from foods lead to elevated plasma phosphate and its associated cardiovascular risks? 107
[G-protein beta3-subunit gene 825T allele and cardiovascular risk] 107
EARLY TOPIC TREATMENT OF EXIT SITE INFECTION IN PERITONEAL DIALYSIS: PROPOSAL OF A NEW PROTOCOL 107
Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients. 106
Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. 106
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis 105
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 105
Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. 105
Bartter's and Gitelman's syndromes 105
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 104
Elderly patient: which vascular access? Choice and management of vascular access in the elderly patient. 104
A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: The start of a good news/bad news story? 103
Ultrasound for the Clinical Management of Vascular Access Cannulation and Needle Position in Hemodialysis Patients 103
Erythropoietin, heme oxygenase-1 and vascular tissue protective effects 103
Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome) 102
Phosphate binders and management of hyperphosphataemia in end-stage renal disease 100
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 100
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients 100
In vivo and in vitro neurotoxic action of plasma ultrafiltrate from uraemic patients 99
Administering antihypertensive drugs after acute ischemic stroke: timing is everything 99
Abnormalities of Gq-mediated cell signaling in Bartter's and Gitelman's syndome 99
Pseudohyperaldosteronism: pathogenetic mechanisms 99
Urinary NO2- and NO3- evaluation by an ion chromatography system 99
Ultrafiltration in heart failure with cardiorenal syndrome. 99
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes 99
"Of coronary arteries and men": The fight of a dialysis patient against his coronary arteries 99
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension 98
Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: studies in humans and in an animal model 98
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 98
Is the red cell morphology really useful to detect the source of hematuria? 98
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 97
Anomalous neutrophil inositol triphosphate production in idiopathic calcium-oxalate nephrolithiasis 97
Aldosterone and thrombosis formation: Implications for ischemic and atherosclerotic heart disease 97
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients. 97
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 97
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes 96
High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular risk. 95
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. 95
Pelvic-ureteric junction obstruction and hypertension with target organ damage: A case report and review of the literature. 95
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 95
SP021CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH 95
Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke 94
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 94
Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus 94
POST-TRANSPLANT HYPERTENSION: ROLE OF NITRIC OXIDE-OXIDATIVE STRESS RELATIONSHIP 93
Obsessive-compulsive and post traumatic avoidance symptoms influence the response to antihypertensive therapy: Relevance in uncontrolled hypertension. 93
Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: effect of a new protocol adopted for a hemodialysis limited assistance center. 93
Mononuclear leukocyte mineralocorticoid receptors: a possible link between aldosterone and atherosclerosis 92
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II 92
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 92
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 92
Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. 92
Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals 91
Aldosterone and refractory hypertension: A prospective cohort study 91
Aldosterone-mediated endothelial remodeling and oxidative stress 91
Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. 91
Totale 11.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.361
article - articoli 131.154
book - libri 481
conference - conferenze 0
curatela - curatele 0
other - altro 1.519
patent - brevetti 154
selected - selezionate 0
volume - volumi 2.194
Totale 282.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.921 0 0 0 0 0 0 0 0 661 584 373 303
2020/20214.665 200 376 218 316 190 406 217 412 648 389 472 821
2021/20226.045 105 848 529 541 266 319 233 658 285 131 551 1.579
2022/20234.614 1.136 395 118 486 818 515 13 301 540 39 187 66
2023/20242.524 116 269 247 178 179 280 202 177 141 83 277 375
2024/20255.428 43 672 457 366 1.420 216 525 878 851 0 0 0
Totale 36.653